New MRI technique may sharpen diagnosis of multiple sclerosis in older adults
NCT ID NCT07444047
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether an advanced MRI technique called Quantitative Susceptibility Mapping (QSM) can better tell apart brain lesions caused by multiple sclerosis (MS) from those due to normal aging or small vessel disease. Researchers will scan 1,000 people aged 50-70 with MS and compare them to a group with small vessel disease. The goal is to help doctors make more accurate diagnoses and treatment decisions for older adults with MS.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oslo University Hospital
RECRUITINGOslo, Oslo, 0450, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection tame stubborn multiple sclerosis?
- The eyes may hold a window to brain health: a trial tests a new marker and treatment
- Could a gentle zapping of the brain ease MS fatigue and brain fog?
- Engineered immune cells take aim at autoimmune diseases
- Can an extra shot boost COVID protection in autoimmune patients?
- CAR-T therapy targets autoimmune diseases, but trial never started